Clinical Trial Update: CRT RENEWAL Registry

View source ↗

Summary

Boston Scientific's CRT RENEWAL Registry trial, which evaluates cardiac resynchronization therapy devices for heart failure, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Cardiac Resynchronization Therapy device

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Heart Failure | Status: COMPLETED